Novo Nordisk is lowering the list prices of its Insulin drug, following Eli Lilly's lead earlier this month.

Share:
More In Science
FDA Updates Ozempic Label
The Food and Drug Administration updated the labeling for Ozempic acknowledging reports of blocked intestines for those that use the medication.
Load More